World Health Organization experts warned Wednesday there could be six months of “hard, hard road ahead” in 2021 before vaccines turn the tide against the coronavirus […]
CytoDel, Inc., a privately-held corporation, today announces the publication of preclinical data on the company’s lead product, Cyto-111, in the peer-reviewed journal, Science Translational Medicine.